Cognition Therapeutics, Inc.
Price Action
Technical Summary
WEAKENINGCognition Therapeutics, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 26), showing significant lag compared to the market leaders. Earnings growth of 64% provides fundamental context to the price action. Investors should exercise caution due to high volatility (145% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $1.28 | -12.84% | BELOW |
| 50 SMA | $1.24 | -9.76% | BELOW |
| 100 SMA | $1.13 | -1.13% | BELOW |
| 150 SMA | $1.25 | -10.28% | BELOW |
| 200 SMA | $1.35 | -17.06% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is CGTX in an uptrend right now?
CGTX has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is CGTX overbought or oversold?
CGTX's RSI (14) is 45. The stock is in neutral territory, neither overbought nor oversold.
Is CGTX outperforming the market?
CGTX has a Relative Strength (RS) Rating of 26 out of 99. CGTX is currently lagging the broader market.
Where is CGTX in its 52-week range?
CGTX is trading at $1.12, which is 29% of its 52-week high ($3.83) and 23% above its 52-week low ($0.29).
How volatile is CGTX?
CGTX has a Beta of 3.07 and 52-week volatility of 145%. It's more volatile than the S&P 500 - expect bigger swings.